Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0U8BD
|
|||
Drug Name |
PMID28447479-Compound-23
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
X-RX, INC
|
|||
Structure |
Download2D MOL |
|||
Formula |
C28H27F7N4O5
|
|||
Canonical SMILES |
CC(C)C(C(=O)N1CCC2(CC1)C(=O)N(C(=O)N2C3=CC=C(C=C3)OC(F)(F)F)C)NC(=O)C4=C(C=CC(=C4)C(F)(F)F)F
|
|||
InChI |
1S/C28H27F7N4O5/c1-15(2)21(36-22(40)19-14-16(27(30,31)32)4-9-20(19)29)23(41)38-12-10-26(11-13-38)24(42)37(3)25(43)39(26)17-5-7-18(8-6-17)44-28(33,34)35/h4-9,14-15,21H,10-13H2,1-3H3,(H,36,40)/t21-/m1/s1
|
|||
InChIKey |
BYITUQUWMVRENA-OAQYLSRUSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Extracellular lysophospholipase D (E-NPP2) | Target Info | . | [1] |
Target's Patent Info | Extracellular lysophospholipase D (E-NPP2) | Target's Patent Info | [1] | |
KEGG Pathway | Ether lipid metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Autotaxin inhibitors: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Jul;27(7):815-829. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.